A Surgical Robot That Can Feel, Plus 4 More Stories
Surgical robots are gaining new senses, new autonomy, and new roles in the operating room.
Each advance matters only when it reaches patients, so the evidence behind every claim matters as much as the claim itself.
UK Surgeons Operate With a Sense of Touch
Channel 4 News reported on October 15, 2026, the first operation in the United Kingdom to use Force Feedback, an addition to the da Vinci 5 robotic system.
The operation repaired a large hernia at Guy’s and St Thomas’ NHS Foundation Trust in London and was led by Professor James Gossage.
Force Feedback measures push, pull and directional forces on tissue and passes them to the surgeon, with sensors reporting about 1,000 times per second.
Professor Gossage said the feedback is reassuring because he previously relied on visual cues, which are harder to read when bleeding occurs.
The report states that early results from the United States show gentler surgery, faster recovery, and shorter operating time, but it cites no study data.
Japan Tests Remote Robotic Surgery on Cancer Patients
Hirosaki University and the Japan Society of Surgery have performed five remote robotic operations on patients with intestinal cancer since August 2026, according to press reports.
The operations used the hinotori system from Japanese company Medicaroid at two hospitals in Aomori Prefecture.
The work is registered as a single-arm clinical study of remote surgical support for gastrointestinal cancer in Japan’s clinical trials registry.
The stated aim is to reduce regional differences in access to surgical care and to ease doctor shortages.
Masaki Mori of Tokai University, who chairs the society’s remote surgery committee, said commercial deployment could come in about two years.
No outcome data for the five operations has been published in the sources reviewed.
Cedars-Sinai Builds a Center for Autonomous Surgery
Cedars-Sinai announced on October 12, 2026, the launch of its Center for Autonomous Robotic Surgery in Los Angeles.
The center aims to develop robots that perform certain surgical tasks autonomously while working alongside surgeons.
Urologist Andrew Hung, who works on AI in robotic surgery, and Michael Yip, who joins from the University of California San Diego, will co-direct it.
Cedars-Sinai announced that it is recruiting clinicians, engineers, and data scientists, and no clinical results have been reported.
A Soft Robot Aims to Reach Stroke Patients Faster
UC Santa Barbara announced on October 14, 2026, a team effort to build a soft autonomous robot that removes blood clots in stroke patients.
The project is led by UC San Diego, includes engineer Elliot Hawkes, and is funded by the ARPA-H Autonomous Interventions and Robotics program.
The robot is a soft, vine-like tube that extends from its tip, which reduces friction and force on blood vessel walls.
Hawkes says safety comes from the physical design rather than from AI, which handles planning and decisions during the procedure.
UC Santa Barbara states that only 12% of eligible stroke patients in the United States receive thrombectomy.
The project is early, with a two-year milestone check and a capstone demonstration planned for the end of year five.
AI Estimates Breast Cancer Recurrence From a Routine MRI
SimBioSys announced on October 15, 2026, that its TumorSight Risk software received FDA clearance, with the clearance letter dated September 25, 2026.
The software combines a pre-treatment breast MRI with age, race, stage, nodal status, and grade to estimate recurrence risk at five and ten years.
It is cleared for adult women with hormone receptor-positive, HER2-negative, Stage I to IIIA breast cancer.
The FDA summary reports a retrospective study of 2,129 patients across four US sites.
In that study, 97.0% of low-risk patients had no recurrence at five years, and 9.8% of high-risk patients had a recurrence within that time.
At ten years, the figures were 91.4% and 26.4%.
Most patients rated high risk did not have a recurrence within five years, so the score sorts patients by risk rather than predicting individual outcomes.
The evidence comes from a retrospective study, not a prospective trial.
Evidence at Very Different Stages
The stories sit at very different stages of evidence, from a hospital first to a cleared software tool to research that has not yet reached a patient.
Reading the sourcing matters as much as reading the headline.
The 2026 Surgical Technology Intelligence Report tracks these developments in depth.
Sources
Channel 4 News, “Revealed: UK’s first operation using a robot that can ‘feel’”: https://channel4news.substack.com/p/revealed-uks-first-operation-using
Japan Registry of Clinical Trials, jRCTs022240038: https://jrct.mhlw.go.jp/en-latest-detail/jRCTs022240038
The Mainichi (Kyodo): https://mainichi.jp/english/articles/20261014/p2g/00m/0sc/053000c
Cedars-Sinai Newsroom: https://www.cedars-sinai.org/newsroom/cedars-sinai-establishes-center-for-autonomous-robotic-surgery/
UC Santa Barbara, The Current: https://news.ucsb.edu/2026/022870/brain-surgery-autonomous-robot-its-possible-and-could-save-lives
FDA 510(k) clearance letter and summary K260023: https://www.accessdata.fda.gov/cdrh_docs/pdf26/K260023.pdf
Related reading